Enhabit, Inc. EHAB
We take great care to ensure that the data presented and summarized in this overview for Enhabit, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding EHAB
View all-
Black Rock Inc. New York, NY7.69MShares$65.6 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.01MShares$42.7 Million0.97% of portfolio
-
8 Knots Management, LLC Dallas, TX4.43MShares$37.8 Million3.92% of portfolio
-
Ubs Group Ag2.91MShares$24.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.91MShares$24.8 Million0.0% of portfolio
-
Arex Capital Management, LP New York, NY2.49MShares$21.2 Million30.16% of portfolio
-
Jana Partners LLC New York, NY2.47MShares$21.1 Million2.13% of portfolio
-
Kent Lake Pr LLC Anasco, PR2MShares$17.1 Million6.61% of portfolio
-
Systematic Financial Management LP Teaneck, NJ2MShares$17 Million0.41% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.95MShares$16.7 Million0.0% of portfolio
Latest Institutional Activity in EHAB
Top Purchases
Top Sells
About EHAB
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Insider Transactions at EHAB
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 10
2025
|
Collin Mc Quiddy Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,096
-100.0%
|
$8,768
$8.58 P/Share
|
Mar 07
2025
|
Tanya Renee Marion Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,457
+22.64%
|
$139,656
$8.02 P/Share
|
Mar 07
2025
|
Dylan C Black General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
19,452
+29.19%
|
$155,616
$8.02 P/Share
|
Mar 07
2025
|
Ryan Solomon Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,173
+17.58%
|
$249,384
$8.02 P/Share
|
Mar 07
2025
|
Barbara Ann Jacobsmeyer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
133,541
+18.75%
|
$1,068,328
$8.02 P/Share
|
Mar 07
2025
|
Collin Mc Quiddy Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+50.0%
|
$47,888
$8.02 P/Share
|
Mar 07
2025
|
Julie Diane Jolley EVP of Home Health Operations |
BUY
Grant, award, or other acquisition
|
Direct |
24,439
+20.94%
|
$195,512
$8.02 P/Share
|
Mar 06
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,604
-5.82%
|
$20,832
$8.02 P/Share
|
Mar 06
2025
|
Tanya Renee Marion Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,638
+14.57%
|
$61,104
$8.02 P/Share
|
Mar 06
2025
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,272
-8.98%
|
$10,176
$8.02 P/Share
|
Mar 06
2025
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,287
+23.23%
|
$34,296
$8.02 P/Share
|
Mar 06
2025
|
Dylan C Black General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,775
-9.1%
|
$22,200
$8.02 P/Share
|
Mar 06
2025
|
Dylan C Black General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,638
+20.03%
|
$61,104
$8.02 P/Share
|
Mar 06
2025
|
Ryan Solomon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
270
-0.23%
|
$2,160
$8.02 P/Share
|
Mar 06
2025
|
Ryan Solomon Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
910
+0.78%
|
$7,280
$8.02 P/Share
|
Mar 06
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,833
-2.38%
|
$86,664
$8.02 P/Share
|
Mar 06
2025
|
Barbara Ann Jacobsmeyer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,822
+5.75%
|
$222,576
$8.02 P/Share
|
Mar 06
2025
|
Collin Mc Quiddy Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-29.7%
|
$3,704
$8.02 P/Share
|
Mar 06
2025
|
Collin Mc Quiddy Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,559
+50.0%
|
$12,472
$8.02 P/Share
|
Mar 06
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,377
-4.06%
|
$19,016
$8.02 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 444K shares |
---|---|
Open market or private purchase | 63K shares |
Payment of exercise price or tax liability | 92.3K shares |
---|---|
Open market or private sale | 1.1K shares |